Grifols Biologicals LLC – FDA 483
Grifols Biologicals, LLC in Los Angeles, CA, was cited for significant manufacturing and quality control deficiencies during an FDA inspection. The firm experienced multiple recalls of its IGIV-C product due to serious allergic reactions, failed to conduct thorough investigations into these issues, and exhibited inadequate procedures for adverse event evaluation, complaint handling, and microbiological contamination prevention. The observations highlight a systemic breakdown in quality systems, including training and laboratory controls, posing a risk to product quality and patient safety.
- Company
- Grifols Biologicals LLC
- Product type
- biologics
ID · 809e049f-363a-4eed-9609-495aa42b600d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.